114 related articles for article (PubMed ID: 34941451)
1. Prospective Study of a Novel Risk Stratification Process for Opioid-Related Harm Reduction in Cancer Patients Seen in an Outpatient Palliative Care Clinic.
Wells-Di Gregorio S; Ehrman S; Bartle-Haring S; Polder J; Marks D; Probst DR; Hartman AD; Adolph M; Taylor R
J Palliat Med; 2022 May; 25(5):783-792. PubMed ID: 34941451
[No Abstract] [Full Text] [Related]
2. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center.
Yennurajalingam S; Edwards T; Arthur JA; Lu Z; Najera J; Nguyen K; Manju J; Kuriakose L; Wu J; Liu D; Williams JL; Reddy SK; Bruera E
Cancer; 2018 Oct; 124(19):3942-3949. PubMed ID: 30192372
[TBL] [Abstract][Full Text] [Related]
3. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.
Brown J; Setnik B; Lee K; Wase L; Roland CL; Cleveland JM; Siegel S; Katz N
J Opioid Manag; 2011; 7(6):467-83. PubMed ID: 22320029
[TBL] [Abstract][Full Text] [Related]
4. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
[TBL] [Abstract][Full Text] [Related]
5. Opioid prescribing practices before and after initiation of palliative care in outpatients.
Muir JC; Scheffey C; Young HM; Vilches AO; Davis MS; Connor SR
J Pain Symptom Manage; 2013 Jun; 45(6):1107-11. PubMed ID: 23017605
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Safe Opioid Prescribing in Outpatient Palliative Care: A Quality Improvement Project.
Bauer MR; Shamas T; Gillespie-Heyman S; Ruskin A
J Pain Symptom Manage; 2021 Aug; 62(2):410-415. PubMed ID: 33647421
[TBL] [Abstract][Full Text] [Related]
7. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.
Slevin KA; Ashburn MA
J Opioid Manag; 2011; 7(2):109-15. PubMed ID: 21561034
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
[TBL] [Abstract][Full Text] [Related]
9. Opioid use by patients in an orthopedics spine clinic.
Mahowald ML; Singh JA; Majeski P
Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Opioid Use and Urine Drug Testing in Outpatient Palliative Care.
Arthur JA; Haider A; Edwards T; Waletich-Flemming J; Reddy S; Bruera E; Hui D
J Palliat Med; 2016 Jul; 19(7):778-82. PubMed ID: 27171327
[TBL] [Abstract][Full Text] [Related]
11. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
Setnik B; Roland CL; Pixton GC; Sommerville KW
Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
[TBL] [Abstract][Full Text] [Related]
12. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.
Moore TM; Jones T; Browder JH; Daffron S; Passik SD
Pain Med; 2009 Nov; 10(8):1426-33. PubMed ID: 20021601
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratification for Opioid Misuse in Children, Adolescents, and Young Adults: A Quality Improvement Project.
Thienprayoon R; Porter K; Tate M; Ashby M; Meyer M
Pediatrics; 2017 Jan; 139(1):. PubMed ID: 27980029
[TBL] [Abstract][Full Text] [Related]
14. Long-term opioid therapy, aberrant behaviors, and substance misuse: comparison of patients treated by resident and attending physicians in a general medical clinic.
Colburn JL; Jasinski DR; Rastegar DA
J Opioid Manag; 2012; 8(3):153-60. PubMed ID: 22798175
[TBL] [Abstract][Full Text] [Related]
15. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.
Webster LR; Webster RM
Pain Med; 2005; 6(6):432-42. PubMed ID: 16336480
[TBL] [Abstract][Full Text] [Related]
16. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Long-Term Opioid Therapy for Chronic Pain in an Outpatient Palliative Medicine Clinic.
Kollas CD; Ruiz K; Laughlin A
J Palliat Med; 2024 Jan; 27(1):31-38. PubMed ID: 37552851
[No Abstract] [Full Text] [Related]
18. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
19. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
[TBL] [Abstract][Full Text] [Related]
20. Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy: A National Survey of Ambulatory Palliative Care Providers.
Merlin JS; Patel K; Thompson N; Kapo J; Keefe F; Liebschutz J; Paice J; Somers T; Starrels J; Childers J; Schenker Y; Ritchie CS
J Pain Symptom Manage; 2019 Jan; 57(1):20-27. PubMed ID: 30342243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
